Molecular mechanisms in lithium-associated renal disease: a systematic review

Soham Rej1,2,3, Shamira Pira4, Victoria Marshe5

  • 1Campbell Family Research Institute, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada. soham.rej@mail.mcgill.ca.

Abstract

Insights

This review explores molecular mechanisms behind lithium-induced kidney damage, focusing on pathways involved in nephrogenic diabetes insipidus. Further research is needed to validate findings in humans and investigate chronic kidney disease for safer lithium use.

Area of Science:

  • Nephrology
  • Pharmacology
  • Molecular Biology

Background:

  • Lithium is a crucial treatment for bipolar disorder and treatment-resistant depression.
  • Renal adverse effects limit lithium's clinical utility.
  • Understanding molecular mechanisms is key to preventing and treating lithium-associated renal disease.

Purpose of the Study:

  • To systematically review molecular mechanisms underlying lithium's effects on the kidney.
  • To identify pathways implicated in lithium-associated nephrogenic diabetes insipidus (NDI) and chronic kidney disease (CKD).

Main Methods:

  • Systematic literature search of MEDLINE, Embase, and PsychINFO databases.
  • Inclusion of original research articles published before November 2015.
  • Focus on studies investigating molecular markers of lithium's impact on NDI and CKD.

Main Results:

  • 71 pre-clinical and 2 clinical studies were identified.
  • Molecular alterations were observed in calcium signaling, inositol monophosphate, prostaglandin, sodium/solute transport, G-protein-coupled receptors, nitric oxide, vasopressin/aquaporin, and inflammation pathways.
  • Most identified mechanisms were linked to NDI, with limited research on CKD.

Conclusions:

  • Future research should validate findings in human subjects.
  • Investigating chronic kidney disease (CKD) is crucial due to its clinical relevance.
  • Improved understanding will inform personalized medicine for safer lithium prescribing and reduced renal adverse events.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
4.2K
Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion01:22

Physiology of the Genitourinary System II: Tubular Reabsorption and Secretion

The kidneys maintain homeostasis through filtration, reabsorption, and secretion. Tubular reabsorption and secretion are crucial in forming urine and regulating electrolytes, water balance, and waste elimination.Tubular Reabsorption and Secretion ProcessesTubular reabsorption is the process that reclaims essential substances such as electrolytes, glucose, amino acids, and water from the glomerular filtrate back into the bloodstream. This is achieved through passive and active transport...
1.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
310
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
5.4K
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
1.0K